TSG Advice Partners’s Bristol-Myers Squibb BMY Stock Holding History

TSG Advice Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$315K	Buy	+5,194	New	+$303K	0.05%	108

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TSG Advice Partners's BMY Position: Q1 2026 in Review

TSG Advice Partners opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 5,194 shares worth $315K. The stake represents 0.05% of the portfolio and ranks #108 among its holdings.

2,532 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

TSG Advice Partners held 5,194 shares of Bristol-Myers Squibb worth $315K as of Q1 2026.
Bristol-Myers Squibb was a new TSG Advice Partners position in Q1 2026.
Bristol-Myers Squibb made up 0.05% of TSG Advice Partners's portfolio in Q1 2026, its #108 holding.
2,532 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on TSG Advice Partners's 13F filing for Q1 2026, filed 24 Apr 2026.